Suntra MedTech joins ARPA-H fetal distress monitoring project

Suntra MedTech Solutions is part of a Carnegie Mellon University-led, nine-institution ARPA-H team building a wearable system to detect fetal hypoxia during labor. The four-year effort aims to improve real-time clinical decisions by replacing hard-to-interpret fetal heart rate monitoring with multi-sensor data and AI.

Why it matters: - The project targets one of obstetrics’ hardest problems: spotting fetal distress in time to guide intervention. - A more reliable system could help clinicians distinguish true oxygen deprivation from false alarms during labor. - The work could improve decision-making in delivery rooms where current monitoring is often ambiguous.

What happened: - Suntra MedTech Solutions, formerly Sunrise Labs, joined a nine-institution team led by Carnegie Mellon University. - The team includes the Children’s Hospital of Philadelphia. - ARPA-H awarded the team up to $39.3 million through its Making Obstetrics Care Smart program. - The award funds a four-year effort to build a wearable system that detects indicators of fetal hypoxia during labor. - Suntra serves as the engineering and systems integration partner.

The details: - The system is designed to be noninvasive. - The platform uses multiple sensors placed on the mother. - AI models will help distinguish true distress from false alarms. - Suntra is responsible for integrating multiple sensor streams into a device that can remain reliable over hours of labor. - The device is being designed to be straightforward to place in a clinical setting. - The work must meet design control and traceability requirements for an FDA-regulated device. - Suntra said the project depends on making the technology dependable, manufacturable and ready for the regulatory path. - Adam Jacobs, Suntra’s chief technology officer and technical lead on the project, said the engineering challenge is combining cutting-edge sensors into one system that can detect subtle physiological signals over a long labor. - Jacobs said the goal is to give care teams actionable information they can rely on for life-and-death decisions. - Suntra said the program draws on four core disciplines: connecting data and devices that were not built to communicate, adding intelligence to regulated medical systems, simplifying the clinician experience and building in security and patient-data protection from the start. - Suntra MedTech Solutions is based in Bedford, New Hampshire. - The company is ISO 13485:2016 certified. - Suntra works across systems, software, hardware, optical and regulatory disciplines for FDA Class II and III medical devices.

Between the lines: - The award signals continued federal interest in applying AI and sensing technology to obstetric care. - Suntra’s role suggests the team needs not just research expertise but also productization and regulatory know-how. - The focus on usability, reliability and traceability points to a system intended for real-world hospital adoption, not just a lab prototype.

What's next: - The team will spend the next four years developing and validating the wearable monitoring system. - Suntra will continue integrating sensor data and preparing the platform for clinical and regulatory requirements. - The project’s success will likely depend on whether the system can perform consistently throughout labor and provide clear clinical signals when fetal oxygenation is at risk.

The bottom line: - Suntra MedTech is bringing engineering and regulatory expertise to an ARPA-H-backed effort that aims to make fetal distress monitoring more accurate, more usable and more actionable in labor and delivery settings.